A detailed history of Pnc Financial Services Group, Inc. transactions in Intra Cellular Therapies, Inc. stock. As of the latest transaction made, Pnc Financial Services Group, Inc. holds 7,549 shares of ITCI stock, worth $645,213. This represents 0.0% of its overall portfolio holdings.

Number of Shares
7,549
Previous 4,378 72.43%
Holding current value
$645,213
Previous $302,000 71.19%
% of portfolio
0.0%
Previous 0.0%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024

BUY
$64.76 - $79.84 $205,353 - $253,172
3,171 Added 72.43%
7,549 $517,000
Q1 2024

May 10, 2024

BUY
$64.37 - $75.65 $37,527 - $44,103
583 Added 15.36%
4,378 $302,000
Q4 2023

Feb 09, 2024

SELL
$46.37 - $73.65 $11,082 - $17,602
-239 Reduced 5.92%
3,795 $271,000
Q3 2023

Nov 13, 2023

SELL
$52.09 - $64.1 $161,322 - $198,517
-3,097 Reduced 43.43%
4,034 $210,000
Q2 2023

Aug 11, 2023

BUY
$54.67 - $66.44 $50,788 - $61,722
929 Added 14.98%
7,131 $451,000
Q1 2023

May 15, 2023

BUY
$43.8 - $56.99 $14,322 - $18,635
327 Added 5.57%
6,202 $335,000
Q4 2022

Feb 10, 2023

SELL
$44.07 - $54.45 $34,550 - $42,688
-784 Reduced 11.77%
5,875 $310,000
Q3 2022

Nov 10, 2022

BUY
$42.7 - $59.99 $32,836 - $46,132
769 Added 13.06%
6,659 $309,000
Q2 2022

Aug 12, 2022

SELL
$43.0 - $65.64 $817 - $1,247
-19 Reduced 0.32%
5,890 $336,000
Q1 2022

May 12, 2022

BUY
$38.74 - $62.09 $46,642 - $74,756
1,204 Added 25.59%
5,909 $361,000
Q4 2021

Feb 11, 2022

BUY
$35.2 - $53.42 $51,814 - $78,634
1,472 Added 45.53%
4,705 $246,000
Q3 2021

Nov 05, 2021

BUY
$28.72 - $42.49 $32,654 - $48,311
1,137 Added 54.25%
3,233 $120,000
Q2 2021

Aug 06, 2021

SELL
$29.3 - $44.5 $9,405 - $14,284
-321 Reduced 13.28%
2,096 $85,000
Q1 2021

May 07, 2021

SELL
$30.8 - $39.51 $3,942 - $5,057
-128 Reduced 5.03%
2,417 $82,000
Q3 2020

Nov 06, 2020

BUY
$17.61 - $31.86 $5,652 - $10,227
321 Added 14.43%
2,545 $65,000
Q4 2019

Feb 07, 2020

BUY
$7.26 - $38.49 $1,147 - $6,081
158 Added 7.65%
2,224 $76,000
Q3 2019

Nov 08, 2019

SELL
$7.47 - $14.03 $709 - $1,332
-95 Reduced 4.4%
2,066 $15,000
Q2 2019

Aug 09, 2019

BUY
$10.65 - $14.29 $1,011 - $1,357
95 Added 4.6%
2,161 $0
Q2 2018

Aug 10, 2018

BUY
$17.33 - $23.4 $34,660 - $46,800
2,000 Added 3030.3%
2,066 $0
Q4 2017

Feb 09, 2018

BUY
$14.27 - $16.79 $941 - $1,108
66
66 $0

Others Institutions Holding ITCI

About Intra-Cellular Therapies, Inc.


  • Ticker ITCI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 94,401,696
  • Market Cap $8.07B
  • Description
  • Intra-Cellular Therapies, Inc., a biopharmaceutical company, develops novel drugs for the treatment of neuropsychiatric and neurologic diseases by targeting intracellular signaling mechanisms within the central nervous system in the United States. The company offers CAPLYTA for the treatment of schizophrenia in adults. It is also involved in dev...
More about ITCI
Track This Portfolio

Track Pnc Financial Services Group, Inc. Portfolio

Follow Pnc Financial Services Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pnc Financial Services Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Pnc Financial Services Group, Inc. with notifications on news.